Ocutrx develops advanced Oculenz AR glasses with eye-tracking ability
Category: #health  By Mateen Dalal  Date: 2019-02-27
  • share
  • Twitter
  • Facebook
  • LinkedIn

Ocutrx develops advanced Oculenz AR glasses with eye-tracking ability

California-based augmented reality (AR) glasses manufacturer, Ocutrx Vision Technologies, LLC, has recently unveiled its new, cutting-edge design for Oculenz™ AR Wear glasses, which is the company’s flagship product.

Sources with knowledge on the matter confirmed that the new aesthetic, being introduced at the Mobile World Congress in Barcelona, was co-developed by the product design team at Karten Design. The redesigned, state-of-the-art Oculenz AR glasses are said to be low-profile and more lightweight in comparison with Mircrosoft’s HoloLens 2, with floating lenses that offer an unobstructed and bright field of view.

The product is suitable for consumer use as well as demanding applications in the medical and industrial environments. Sources said that the first market for the Oculenz AR would be for patients having macular degeneration and other low vision problems.

Ocutrx is apparently the world’s first heads-up AR manufacturer to integrate eye-tracking and cellular connectivity fully into the design of its headset. The Oculenz AR consists of eye-tracking cameras and infra-red (IR) illumination mounted in a nose bridge that provides a clear line of sight to the eye and does not obstruct the user’s field of view. Oculenz can be adapted easily to various AR applications owing to this centralized component design, the sources mentioned.

Ocutrx’s CEO and CTO, Michael H. Freeman believes the new cellular-connected design for AR Wear does not only represent a step forward for the company, but for the entire AR Wear market. He state an example, saying that a surgeon in an operating room would now benefit from the very light weight and redesigned head strap which offers comfort for extended use periods, while keeping the headset secure during a surgery for 3D visualization.

According to the sources, Oculenz AR would prove to be of great value for age-related macular degeneration patients. The eyeglass inspired design supposedly assists in relieving the common stigma associated with worn medical products, whereas a tinted upper lens helps in visualizing obscure SLAM sensors along with the 4K cameras that are embedded in the glasses.

  • share
  • Twitter
  • Facebook
  • LinkedIn


About Author

Mateen Dalal    

Mateen Dalal

Mateen has completed his Bachelor’s degree in electronics and telecommunication engineering, post which he lent his proficiency to the industry, working as a quality and test engineer. Drawn intricately toward the field of content creation however, Mateen soon switc...

Read More

More News By Mateen Dalal

Ambrx partners with Bristol-Meyers to initiate Relaxin clinical trial
Ambrx partners with Bristol-Meyers to initiate Relaxin clinical trial
By Mateen Dalal

Ambrx will receive additional development payments with Bristol-Meyers’ initiation of the Phase 1 clinical trial for Relaxin Ambrx Inc., a biopharmaceutical company focused on developing protein therapeutics, has recently announced that Bristo...

LifeSpan Bio acquires Everest Biotech to expand reagent portfolio
LifeSpan Bio acquires Everest Biotech to expand reagent portfolio
By Mateen Dalal

The transaction will be LifeSpan BioSciences’ second investment this year following its Nordic-MUbio acquisition LifeSpan BioSciences (LSBio), a provider of life science research reagents and antibodies, has recently announced that it has acqu...

AbbVie buys Mavupharma to target STING pathway for cancer treatment
AbbVie buys Mavupharma to target STING pathway for cancer treatment
By Mateen Dalal

AbbVie Inc., a US-based pharmaceutical company recently announced acquisition of Mavupharma, a Seattle-based biopharmaceutical company, which is focused on innovative strategies to target the STimulator of INterferon Genes pathway for the treatment o...